Cellarity Overview
- Founded
- 2017
- Status
- Private
- Employees
- 95
- Latest Deal Type
- Mezzanine
- Latest Deal Amount
- $30.3M
- Investors
- 6
Cellarity General Information
Description
Operator of a biomedical platform intended to digitize the molecular information in cells to elucidate how they behave in health and disease. The company's platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviours, unravel the network dynamics that govern those behaviours, and generate medicines that can direct them, enabling companies to increase the success rate and speed of drug discovery.
Contact Information
Website
www.cellarity.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Primary Office
- 100 Technology Square
- 6th Floor
- Cambridge, MA 02140
- United States
+1 (617) 000-0000
Cellarity Timeline
Cellarity Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Mezzanine | 08-Dec-2021 | $30.3M | 00000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 25-Feb-2021 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 10-Dec-2019 | $50M | $50M | 000.00 | Completed | Generating Revenue |
Cellarity Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.00 |
| Series A-1 | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.000 | |
| Series A | 11,399,900 | $0.001000 | $1 | $1 | 1x | $1 | 17.4% |
Cellarity Executive Team (11)
Cellarity Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Avak Kahvejian Ph.D | Cellarity | Co-Founder & Board Member | 000 0000 |
| Carl Decicco Ph.D | Self | Board Member | 000 0000 |
| Fabrice Chouraqui | Cellarity | Co-Chief Executive Officer & Board Member | 000 0000 |
| James Collins Ph.D | Self | Co-Founder & Board Member | 000 0000 |
| Marcello Damiani | Self | Board Member | 000 0000 |
Cellarity Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCellarity Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Hercules Capital BDC | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | |
| Ahren Innovation Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| BlackRock | Asset Manager | Minority | 000 0000 | 000000 0 | |
| Pictet | Asset Manager | Minority | 000 0000 | 000000 0 | |
| The Baupost Group | Hedge Fund | Minority | 000 0000 | 000000 0 |